These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23882036)

  • 41. Screening for type 2 diabetes mellitus in patients with mental illness: application of a self-assessment score for diabetes mellitus risk.
    Shin JK; Shortridge-Baggett LM; Sachmechi I; Barron C; Chiu YL; Bajracharya B; Bang H
    Psychiatry Res; 2014 Dec; 220(3):1037-42. PubMed ID: 25223258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examining the impact of genetic testing for type 2 diabetes on health behaviors: study protocol for a randomized controlled trial.
    Voils CI; Coffman CJ; Edelman D; Maciejewski ML; Grubber JM; Sadeghpour A; Cho A; McKenzie J; Blanpain F; Scheuner M; Sandelowski M; Gallagher MP; Ginsburg GS; Yancy WS
    Trials; 2012 Aug; 13():121. PubMed ID: 22852560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Family awareness. Monitoring diabetes risk.
    Hieronymus L; Geil P
    Diabetes Self Manag; 2014; 31(4):22-4, 26. PubMed ID: 25137832
    [No Abstract]   [Full Text] [Related]  

  • 45. Usefulness of a systematic screening of carotid atherosclerosis in asymptomatic people with type 2 diabetes for cardiovascular risk reclassification.
    Helfre M; Grange C; Riche B; Maucort-Boulch D; Thivolet C; Vouillarmet J
    Ann Endocrinol (Paris); 2017 Feb; 78(1):14-19. PubMed ID: 28185650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevention of type 2 diabetes mellitus].
    Palitzsch D; Bührlen M
    MMW Fortschr Med; 2012 May; 154(9):45-8. PubMed ID: 22715631
    [No Abstract]   [Full Text] [Related]  

  • 47. [Risk-stratified screening for diabetes in adults: results of the first investigation in Hungary].
    Winkler G; Hidvégi T; Vándorfi G; Jermendy G
    Orv Hetil; 2010 Apr; 151(17):691-6. PubMed ID: 20388612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Value of questionnaires for screening in diagnosis of diabetes].
    Wascher T
    Acta Med Austriaca Suppl; 2002; 56():6-8. PubMed ID: 12436704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Screening for type 2 diabetes is justified].
    Andersson DK; Petersson C
    Lakartidningen; 1998 Nov; 95(46):5167-70, 5175. PubMed ID: 9842189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study.
    Jølle A; Midthjell K; Holmen J; Carlsen SM; Tuomilehto J; Bjørngaard JH; Åsvold BO
    BMJ Open Diabetes Res Care; 2019; 7(1):e000769. PubMed ID: 31803483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Screening of type 2 diabetes, the French guidelines].
    Simon D; Cogneau J; Sauvanet JP
    Soins; 2004 Apr; (684 Pt 2):29-32. PubMed ID: 15151090
    [No Abstract]   [Full Text] [Related]  

  • 52. Equal Opportunity.
    Tsai A
    Diabetes Forecast; 2015; 68(6):63-9. PubMed ID: 26665806
    [No Abstract]   [Full Text] [Related]  

  • 53. The Interaction of Genetic Predisposition and Socioeconomic Position With Type 2 Diabetes Mellitus: Cross-Sectional and Longitudinal Analyses From the Lifelines Cohort and Biobank Study.
    van Zon SKR; Reijneveld SA; van der Most PJ; Swertz MA; Bültmann U; Snieder H
    Psychosom Med; 2018 Apr; 80(3):252-262. PubMed ID: 29381659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experts urge better care for women with gestational diabetes.
    Traynor K
    Am J Health Syst Pharm; 2006 Dec; 63(24):2430-1. PubMed ID: 17158686
    [No Abstract]   [Full Text] [Related]  

  • 55. The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2.
    Endler G; Exner M; Raith M; Marculescu R; Mannhalter C; Endler L; Wojta J; Huber K; Wagner OF
    Thromb Res; 2003; 112(1-2):47-50. PubMed ID: 15013273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening for type 2 diabetes in primary care.
    Schwarz PE; Li J; Bornstein SR
    BMJ; 2009 Mar; 338():b973. PubMed ID: 19297313
    [No Abstract]   [Full Text] [Related]  

  • 57. Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study.
    Venuraju SM; Lahiri A; Jeevarethinam A; Cohen M; Darko D; Nair D; Rosenthal M; Rakhit RD
    Cardiovasc Diabetol; 2019 Apr; 18(1):51. PubMed ID: 31014330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk assessment of Pakistani individuals for diabetes (RAPID).
    Riaz M; Basit A; Hydrie MZ; Shaheen F; Hussain A; Hakeem R; Shera AS
    Prim Care Diabetes; 2012 Dec; 6(4):297-302. PubMed ID: 22560662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body fat distribution and the risk of non-insulin-dependent diabetes mellitus in the Omani population.
    al-Asfoor DH; al-Lawati JA; Mohammed AJ
    East Mediterr Health J; 1999 Jan; 5(1):14-20. PubMed ID: 10793776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
    Saaristo T; Peltonen M; Lindström J; Saarikoski L; Sundvall J; Eriksson JG; Tuomilehto J
    Diab Vasc Dis Res; 2005 May; 2(2):67-72. PubMed ID: 16305061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.